Ridge Preservation and Augmentation Using a Carbonated Apatite Bone Graft Substitute: A Case Series

The newly developed mineral carbonated apatite has recently been proposed as a bone graft material for bone regenerative treatment in implant therapy. This case series details the clinical and radiographic outcomes of ridge preservation and ridge augmentation using only carbonated apatite as bone graft material for implant treatment. Twenty patients (36 sites) who required bone regeneration and implant placement were retrospectively assessed. Simultaneous carbonated apatite implant placement was performed using the simultaneous ridge preservation or augmentation approach on 24 sites in 13 patients with sufficient bone quantity for primary stabilization based on preoperative evaluation results. A staged ridge preservation or augmentation approach was used for the remaining 12 sites in seven patients with insufficient bone quantity. The mean regenerated bone height for each treatment method was as follows: simultaneous preservation, 7.4 +/- 3.3 mm; simultaneous augmentation, 3.6 +/- 2.3 mm; staged preservation, 7.2 +/- 4.5 mm; and staged augmentation, 6.1 +/- 2.7 mm. The mean regenerated bone width for each treatment method was as follows: simultaneous preservation, 6.5 +/- 2.9 mm; simultaneous augmentation, 3.3 +/- 2.5 mm; staged preservation, 5.5 +/- 1.7 mm; and staged augmentation, 3.5 +/- 1.9 mm. Ultimately, the use of carbonated apatite alone as a bone graft material in implant therapy resulted in stable and favorable bone regeneration.